In most people, an asymptomatic UTI (bacteria in the urine without symptoms) does not need treatment. Major guidelines strongly recommend against screening for or treating this condition in healthy adults, older adults, people with diabetes, those with indwelling catheters, and people with spinal cord injuries. The only two groups where treatment is clearly recommended are pregnant women and people about to undergo urologic procedures that involve mucosal bleeding.
What Asymptomatic Bacteriuria Actually Is
Asymptomatic bacteriuria (ASB) means bacteria are growing in your urine at significant levels, but you have no urinary symptoms: no burning, no urgency, no frequency, no pelvic pain. It’s surprisingly common. In long-term care facilities, 25 to 50 percent of women and 15 to 35 percent of men have it at any given time. Among older adults living independently, the numbers are lower but still substantial.
The key distinction is that bacteria in the urine is not the same thing as an infection that needs treatment. Your body can harbor bacteria in the urinary tract without those bacteria causing inflammation or tissue damage. A positive urine culture alone, without symptoms, does not equal a UTI.
Why Treatment Is Not Recommended for Most People
The Infectious Diseases Society of America (IDSA) has issued clear guidance on this since 2005, reaffirming the position in a 2019 update: do not screen for or treat ASB in healthy non-pregnant adults. That recommendation covers a wide range of people, including older women and men living in the community or in long-term care facilities, and people with indwelling urinary catheters or spinal cord injuries.
The reasoning is straightforward. Treating ASB with antibiotics does not reduce your risk of developing a symptomatic UTI later, does not lower your risk of serious complications like kidney infection or sepsis, and does not reduce your risk of death. What it does do is expose you to real harm: antibiotic side effects, a higher chance of developing a serious intestinal infection caused by C. difficile, and colonization with drug-resistant bacteria that become harder to treat if you do develop a real infection later.
Repeated antibiotic treatment for bacteriuria in people with long-term catheters is a particularly significant driver of multidrug-resistant organisms, and most of that antibiotic use is inappropriate.
Diabetes Does Not Change the Answer
People with diabetes sometimes worry that bacteria in their urine is more dangerous because of their condition. A well-designed trial published in the New England Journal of Medicine tested this directly, randomizing diabetic women with ASB to receive either antibiotics or placebo and following them for up to 36 months. The results were unambiguous: treatment made no difference. About 40 percent of women in both groups eventually developed a symptomatic UTI, and the rates of kidney infection and hospitalization were statistically identical.
The only measurable difference was antibiotic exposure. Women in the treatment group used nearly five times as many days of antibiotics for urinary tract issues compared to the placebo group. Diabetes is not an indication for screening or treating ASB.
Pregnancy Is the Major Exception
Pregnant women are the one population where screening for and treating ASB is firmly recommended. The U.S. Preventive Services Task Force gives this a Grade B recommendation, meaning there is moderate certainty of meaningful benefit. ACOG and IDSA agree.
The reason pregnancy changes the calculus is that untreated bacteriuria in pregnant women has a much higher risk of progressing to pyelonephritis (kidney infection), which carries serious maternal complications including sepsis and acute respiratory distress syndrome. UTIs during pregnancy are also associated with increased rates of preterm delivery and low birth weight. Multiple studies have shown that screening with a urine culture and treating positive results significantly reduces the incidence of pyelonephritis during pregnancy. Standard screening typically happens during the first trimester or at the first prenatal visit.
Urologic Procedures That Breach the Mucosa
The second established exception is for people about to undergo urologic surgery where mucosal bleeding is expected. This includes procedures like transurethral resection of the prostate and other operations where instruments pass through the urinary tract lining. In these cases, bacteria already present in the urine can enter the bloodstream through the disrupted tissue, potentially causing bloodstream infection. Screening with a urine culture before the procedure and treating any bacteriuria found is standard practice.
Kidney Transplant Recipients
For people who have received a kidney transplant, the guidance has narrowed over time. Current expert panels recommend against screening for and treating ASB beyond the first month after transplantation, supported by high-quality evidence. During that initial post-transplant window, when immunosuppression is most intense and surgical sites are healing, closer monitoring makes sense. After that, treating ASB in transplant recipients follows the same logic as in other populations: antibiotics add risk without clear benefit. If ASB is detected, stricter monitoring and non-antibiotic prevention strategies are preferred over reflexive prescribing.
Catheters and Long-Term Care
Bacteria in the urine are nearly universal in people with chronic indwelling catheters. Treating that bacteriuria when there are no symptoms rarely prevents complications like kidney infection or bloodstream infection, and it reliably promotes antibiotic resistance. Guidelines are explicit: do not treat catheter-associated bacteriuria or funguria in the absence of symptoms, unless the patient falls into a high-risk category like pregnancy or upcoming urologic surgery.
In nursing homes and long-term care facilities, the overtreatment problem is especially pronounced. Nonspecific symptoms common in older adults, such as confusion, fatigue, falls, and agitation, are frequently attributed to a “UTI” based solely on a positive urine culture. But studies of inflammatory markers in older residents with bacteriuria have not been able to reliably distinguish between ASB and symptomatic infection using these vague symptoms. The IDSA makes a strong recommendation against screening for or treating ASB in this population, noting high-quality evidence of harm from unnecessary antibiotics and low-quality evidence of any benefit.
Why Positive Cultures Get Treated Anyway
Despite clear guidelines, overtreatment of ASB remains one of the most common examples of inappropriate antibiotic use in hospitals and nursing homes. The pattern typically starts with a urine culture ordered for vague or unrelated reasons. Once bacteria show up on a lab report, physicians feel pressure to prescribe something. Quality improvement programs targeting this problem have shown that education and decision-support tools can reduce unnecessary prescriptions, but the reflex to treat a positive culture is deeply ingrained.
If you’ve been told you have bacteria in your urine but have no urinary symptoms, it is reasonable to ask your provider whether treatment is actually indicated. In most situations, the evidence-based answer is no.